GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » COGS-to-Revenue

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) COGS-to-Revenue : 0.17 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC COGS-to-Revenue?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Cost of Goods Sold for the three months ended in Dec. 2023 was ₽12.0 Mil. Its Revenue for the three months ended in Dec. 2023 was ₽70.1 Mil.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's COGS to Revenue for the three months ended in Dec. 2023 was 0.17.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Gross Margin % for the three months ended in Dec. 2023 was 82.91%.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC COGS-to-Revenue Historical Data

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC COGS-to-Revenue Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial - - 0.23 0.20 0.17

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.15 0.18 - 0.17

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC COGS-to-Revenue Calculation

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=47.949 / 283.512
=0.17

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=11.988 / 70.132
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC  (MIC:GEMA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 11.988 / 70.132
=82.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » COGS-to-Revenue
Comparable Companies
DV EGAN TYL BSY MKTW ENFN DHX RDVT MANH PCTY HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS
Traded in Other Exchanges
N/A
Address
St. Gubkina, 3, Building 1, Floor 1, Pom. I, r. 24, Moscow, RUS, 119333
Website
https://www.gemabank.ru
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Headlines

No Headlines